IRIS Accounts Production v25.4.0.155 10091706 director 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 10091706 2024-03-31 10091706 2025-03-31 10091706 2024-04-01 2025-03-31 10091706 2023-03-31 10091706 2023-04-01 2024-03-31 10091706 2024-03-31 10091706 ns15:EnglandWales 2024-04-01 2025-03-31 10091706 ns14:PoundSterling 2024-04-01 2025-03-31 10091706 ns10:Director1 2024-04-01 2025-03-31 10091706 ns10:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10091706 ns10:SmallEntities 2024-04-01 2025-03-31 10091706 ns10:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10091706 ns10:SmallCompaniesRegimeForDirectorsReport 2024-04-01 2025-03-31 10091706 ns10:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10091706 ns10:FullAccounts 2024-04-01 2025-03-31 10091706 ns10:RegisteredOffice 2024-04-01 2025-03-31 10091706 ns5:CurrentFinancialInstruments 2025-03-31 10091706 ns5:CurrentFinancialInstruments 2024-03-31 10091706 ns5:ShareCapital 2025-03-31 10091706 ns5:ShareCapital 2024-03-31 10091706 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 10091706 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 10091706 ns5:PlantMachinery 2024-04-01 2025-03-31 10091706 ns5:ComputerEquipment 2024-04-01 2025-03-31 10091706 ns5:PlantMachinery 2024-03-31 10091706 ns5:ComputerEquipment 2024-03-31 10091706 ns5:PlantMachinery 2025-03-31 10091706 ns5:ComputerEquipment 2025-03-31 10091706 ns5:PlantMachinery 2024-03-31 10091706 ns5:ComputerEquipment 2024-03-31 10091706 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31 10091706 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-03-31

REGISTERED NUMBER: 10091706 (England and Wales)

DOCTORANA SOLUTIONS LIMITED

Financial Statements

for the Year Ended 31 March 2025

DOCTORANA SOLUTIONS LIMITED (REGISTERED NUMBER: 10091706) |

Contents of the Financial Statements

for the year ended 31 March 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| DOCTORANA SOLUTIONS LIMITED |

Company Information

for the year ended 31 March 2025

| Director: | A M Aguirregabiria

| Registered office: | Suite 13

| 36-42 Kings Road

| London

| SW3 4UD

| Registered number: | 10091706 (England and Wales)

DOCTORANA SOLUTIONS LIMITED (REGISTERED NUMBER: 10091706) |

Balance Sheet

31 March 2025

2025 | 2024 |

| Notes | £ | £

Fixed assets

Tangible assets | 4 | - |  | 5,247 |  |

Current assets

Debtors | 5 | 26,088 |  | 18,916 |  |

Cash at bank | 149,563 |  | 151,489 |  |

175,651 |  | 170,405 |  |

Creditors

Amounts falling due within one year | 6 | (53,925 | ) | (37,687 | ) |

Net current assets | 121,726 |  | 132,718 |  |

Total assets less current liabilities | 121,726 |  | 137,965 |  |

Capital and reserves

Called up share capital | 10 |  | 10 |  |

Retained earnings | 121,716 |  | 137,955 |  |

121,726 |  | 137,965 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 November 2025 and were signed by:

A M Aguirregabiria - Director

DOCTORANA SOLUTIONS LIMITED (REGISTERED NUMBER: 10091706) |

Notes to the Financial Statements

for the year ended 31 March 2025

1. | Statutory information

| Doctorana Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | Accounting policies

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover represents amounts receivable for services provided in the year .

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Equipment | - | 25% on cost

| Computer equipment | - | 25% on cost

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| Going concern

| These financial statements have been prepared on a going concern basis.

| The current economic conditions present increased risks for all businesses. In response to such conditions, the director has carefully considered these risks including an assessment on uncertainty on future trading projection for a period of at least 12 months from the date of signing the financial statements, and the extent to which they might affect the preparation of the financial statements on a going concern basis.

| Based on assessment, the director considers that the Company maintains an appropriate level of liquidity, sufficient to meet the demands of the business including any capital and servicing obligations and external debt liabilities.

| In addition, the Company's assets are assessed for recoverability on a regular basis, and the director considers that the Company is not exposed to losses on these assets which would affect their decision to adopt the going concern basis.

| The director has a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future and that there are no material uncertainties that lead to significant doubts upon the Company's ability to continue as a going concern. Thus the director has continued to adopt the going concern basis of accounting in preparing these financial statements.

DOCTORANA SOLUTIONS LIMITED (REGISTERED NUMBER: 10091706) |

Notes to the Financial Statements - continued

for the year ended 31 March 2025

2. | Accounting policies - continued

| Financial instruments

| Financial assets and liabilities are recognised when the Company becomes party to the contractual provisions of the financial instrument. The Company holds financial instruments which comprise cash and cash equivalents, trade and other receivables, equity investments, trade and other payables, loans and borrowings. The company has chosen to apply the provisions of Section 11 Basic Financial Instruments and Section 12 Other Financial Instruments in full.

| Financial assets / liabilities - classified as basic financial instruments

| (i) Cash and cash equivalents

| This includes cash in hand, deposits held with banks, and other short-term highly liquid investments with original maturities of three months or less.

| (ii) Trade and other receivables

| Trade and other receivables are initially recognised at the transaction price, including any transaction costs, and subsequently measured at amortised cost including the effective interest method, less any provision for impairment. Amounts that are receivable within one year are measured at the undiscounted amount of the cash expected to be received, net of any impairment.

| At the end of each reporting period, the Company assesses whether there is objective evidence that an receivable amount may be impaired. A provision for impairment is established when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. The amount of the provision is the difference between the asset's carrying amount and the present value of the estimated future cash flows, discounted at the effective interest rate. The amount of the provision is recognised immediately in profit or loss.

| (iii) Trade and other payables and loans and borrowings

| Trade and other payables and loans and borrowings are initially measured at the transaction price, including any transaction price, including any transaction costs, and subsequently measured at amortised cost using the effective interest method.

3. | Employees and directors

| The average number of employees during the year was 1 (2024 - 1 ) .

4. | Tangible fixed assets

Computer |

Equipment | equipment | Totals |

| £ | £ | £

| Cost

| At 1 April 2024

| and 31 March 2025 | 52,758 |  | 16,292 |  | 69,050 |  |

| Depreciation

| At 1 April 2024 | 47,511 |  | 16,292 |  | 63,803 |  |

| Charge for year | 5,247 |  | - |  | 5,247 |  |

| At 31 March 2025 | 52,758 |  | 16,292 |  | 69,050 |  |

| Net book value

| At 31 March 2025 | - |  | - |  | - |  |

| At 31 March 2024 | 5,247 |  | - |  | 5,247 |  |

DOCTORANA SOLUTIONS LIMITED (REGISTERED NUMBER: 10091706) |

Notes to the Financial Statements - continued

for the year ended 31 March 2025

5. | Debtors: amounts falling due within one year |

2025 | 2024 |

| £ | £

| Trade debtors | 23,695 |  | 18,916 |  |

| Prepayments and accrued income | 2,393 |  | - |  |

26,088 |  | 18,916 |  |

6. | Creditors: amounts falling due within one year |

2025 | 2024 |

| £ | £

| Trade creditors | 2,149 |  | - |  |

| Tax | 4,750 |  | - |  |

| Social security and other taxes | 661 |  | 734 |  |

| Directors' current accounts | - |  | 1,109 |  |

| Accruals and deferred income | 46,365 |  | 35,844 |  |

53,925 |  | 37,687 |  |